Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: Corteva - The Untold Story

Bullish on Corn and Soybeans? This Stock Just Hit New All-Time Highs.

Corteva (CTVA) exhibits strong technical momentum and recently hit a new all-time high. Shares are up more than 50% over the past 52 weeks. Analyst sentiment is overwhelmingly positive with most major firms rating CTVA a “Buy.” Low short interest and strong support from both Wall Street and individual investors...

Barchart

Is Corteva Stock Underperforming the Nasdaq?

While Corteva has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

First Thing: DoJ accused of cover-up after lawmakers view unredacted Epstein files

Jamie Raskin, House judiciary ranking member, says ‘mysterious redactions’ obscure abusers’ names. Plus, RFK Jr accused of misleading Senate

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

US chemical giant to stop producing herbicide called ‘toxic cocktail’ by critics

Corteva will discontinue a mixture of an Agent Orange ingredient and glyphosate, but another of its herbicides will still use Vietnam war-era defoliant

The Guardian - US

Corteva Stock: Is Wall Street Bullish or Bearish?

Are Wall Street analysts bullish or bearish on Corteva’s stock post its Q4 earnings release?

Barchart

Here's What to Expect From Corteva's Next Earnings Report

Corteva is scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a double-digit earnings drop.

Barchart

Is Corteva Stock Underperforming the S&P 500?

Corteva has underperformed the S&P 500 over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Corteva Stock: Analyst Estimates & Ratings

While Corteva has trailed behind the S&P 500 Index over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

Earnings Preview: What to Expect From Corteva's Report

Corteva is all set to release its fiscal third-quarter earnings next month, and analysts project earnings in line with the year-ago quarter.

Barchart

These 3 Stocks Just Got Upgraded—and Could Keep Climbing

These companies have all seen notable interest from analysts that have recently upgraded their ratings, a potential signal of gains ahead.

MarketBeat

Top 3 Materials Stocks That Could Lead To Your Biggest Gains In October

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

Benzinga

Agri-Science Giant Corteva Eyes Breakup To Shield Seed Unit From Future Risks: Report

Corteva Inc. (NYSE:CTVA) is reportedly considering a major restructuring that would split its seed and pesticide operations into two separate entities. The pure-play agriculture company, valued at roughly $50 billion, could announce its plans soon if negotiations stay on track.

Benzinga

How Is Corteva's Stock Performance Compared to Other Agricultural Inputs Stocks?

Due to Corteva's outperformance relative to its industry peers over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects.

Barchart

Do Wall Street Analysts Like Corteva Stock?

Corteva has outperformed the broader market over the past year, and analysts remain strongly bullish on the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Corteva's Quarterly Earnings Preview: What You Need to Know

Corteva is expected to announce its second-quarter results in the upcoming month, and analysts expect a low-single-digit growth in earnings.

Barchart

Corteva Stock Is Blooming and New Highs Are in Sight

Corteva (CTVA) shows strong technical momentum, trading near its 52-week high. CTVA has a 100% technical “Buy” signal via Barchart. Shares are up 33% in the past year, and more than 25% in the year to date. The stock is outperforming its peers and boasts strong fundamentals. Today’s Featured Stock:...

Barchart

Corteva Stock Outlook: Is Wall Street Bullish or Bearish?

Corteva has outpaced the broader market over the past year, and Wall Street analysts maintain a highly optimistic outlook on the stock’s prospects.

Barchart

Is Corteva Stock Outperforming the Dow?

As Corteva has outperformed the Dow recently, analysts remain moderately optimistic about the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Are Wall Street Analysts Predicting Corteva Stock Will Climb or Sink?

Despite Corteva's underperformance relative to the S&P 500 Index over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

MarketBeat

How Trump’s AI Push Could Boost These 3 Agriculture Stocks

President Trump's push for technological developments in the agriculture sector could start to expand margins and EPS in these 3 stocks.

Barchart

Corteva Earnings Preview: What to Expect

Corteva is scheduled to release its fourth-quarter earnings next month, and analysts anticipate a significant triple-digit profit surge.

MarketBeat

2 Agriculture Stocks To Benefit From a Trump Presidency in 2025

President Trump's return to the White House could mean lower corporate taxes, less red tape, favorable trade deals to help the U.S. agriculture industry.

MarketBeat

3 Hot Buyback Announcements That Will Drive Value in 2025

Share buybacks will boost these stocks' prices in 2025 and beyond. Robust cash flow and healthy balance sheets are two common factors.

MarketBeat

3 Stocks That Authorized $1 Billion Stock Buybacks to Boost Value

Discover three major stock buybacks of 2024. Williams-Sonoma, BJ’s, and Corteva make headlines with billion-dollar programs driving investor sentiment.

Barchart

Is Wall Street Bullish or Bearish on Corteva Stock?

Corteva has underperformed the S&P 500 over the past year, yet analysts remain moderately bullish on the stock’s prospects.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Transparency International

Read news from The Economist, FT, and more,
with one subscription

Places

United States

363,469 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.